Click for best price
Drugs for Hormonal Replacement Therapy Market Size, Share 2023
This report contains market size and forecasts of Drugs for Hormonal Replacement Therapy in Global, including the following market information:
The global Drugs for Hormonal Replacement Therapy market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Estrogen Replacement Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Drugs for Hormonal Replacement Therapy include Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Abbott, Mylan Laboratories, Merck & Co. and Hisamitsu Pharmaceutical Co. Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Hormonal Replacement Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Hormonal Replacement Therapy Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, by Type, 2022 (%)
- Estrogen Replacement Therapy
- Human Growth Hormone Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
Global Drugs for Hormonal Replacement Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, by Application, 2022 (%)
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Menopause
- Others
Global Drugs for Hormonal Replacement Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Drugs for Hormonal Replacement Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Drugs for Hormonal Replacement Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- Eli Lilly and Company
- Abbott
- Mylan Laboratories
- Merck & Co.
- Hisamitsu Pharmaceutical Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- F.Hoffmann-La Roche
- Noven Pharmaceuticals Inc.
- Orion Pharma AB
- Allergan Plc.
- QuatRx Pharmaceuticals
- Wyeth
- Amgen Inc.
- Roche
- Genentech
- TherapeuticsMD
| Report Attributes |
Report Details |
| Report Title |
Drugs for Hormonal Replacement Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Hormonal Replacement Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Hormonal Replacement Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Hormonal Replacement Therapy Overall Market Size
2.1 Global Drugs for Hormonal Replacement Therapy Market Size: 2022 VS 2030
2.2 Global Drugs for Hormonal Replacement Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Hormonal Replacement Therapy Players in Global Market
3.2 Top Global Drugs for Hormonal Replacement Therapy Companies Ranked by Revenue
3.3 Global Drugs for Hormonal Replacement Therapy Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Hormonal Replacement Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Hormonal Replacement Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Hormonal Replacement Therapy Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Hormonal Replacement Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Hormonal Replacement Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs for Hormonal Replacement Therapy Market Size Markets, 2022 & 2030
4.1.2 Estrogen Replacement Therapy
4.1.3 Human Growth Hormone Replacement Therapy
4.1.4 Thyroid Replacement Therapy
4.1.5 Testosterone Replacement Therapy
4.2 By Type - Global Drugs for Hormonal Replacement Therapy Revenue & Forecasts
4.2.1 By Type - Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Hormonal Replacement Therapy Revenue, 2023-2030
4.2.3 By Type - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Hormonal Replacement Therapy Market Size, 2022 & 2030
5.1.2 Hypothyroidism
5.1.3 Male Hypogonadism
5.1.4 Growth Hormone Deficiency
5.1.5 Menopause
5.1.6 Others
5.2 By Application - Global Drugs for Hormonal Replacement Therapy Revenue & Forecasts
5.2.1 By Application - Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Hormonal Replacement Therapy Revenue, 2023-2030
5.2.3 By Application - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Drugs for Hormonal Replacement Therapy Market Size, 2022 & 2030
6.2 By Region - Global Drugs for Hormonal Replacement Therapy Revenue & Forecasts
6.2.1 By Region - Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Hormonal Replacement Therapy Revenue, 2023-2030
6.2.3 By Region - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Drugs for Hormonal Replacement Therapy Revenue, 2018-2030
6.3.2 US Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.3.3 Canada Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.3.4 Mexico Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Drugs for Hormonal Replacement Therapy Revenue, 2018-2030
6.4.2 Germany Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.4.3 France Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.4.4 U.K. Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.4.5 Italy Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.4.6 Russia Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.4.8 Benelux Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Drugs for Hormonal Replacement Therapy Revenue, 2018-2030
6.5.2 China Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.5.3 Japan Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.5.4 South Korea Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.5.6 India Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Drugs for Hormonal Replacement Therapy Revenue, 2018-2030
6.6.2 Brazil Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.6.3 Argentina Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue, 2018-2030
6.7.2 Turkey Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.7.3 Israel Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
6.7.5 UAE Drugs for Hormonal Replacement Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Drugs for Hormonal Replacement Therapy Major Product Offerings
7.1.4 Novartis AG Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News
7.2 Bayer AG
7.2.1 Bayer AG Corporate Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Drugs for Hormonal Replacement Therapy Major Product Offerings
7.2.4 Bayer AG Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.2.5 Bayer AG Key News
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporate Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.3.4 Pfizer Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Inc. Key News
7.4 Novo Nordisk A/S
7.4.1 Novo Nordisk A/S Corporate Summary
7.4.2 Novo Nordisk A/S Business Overview
7.4.3 Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Major Product Offerings
7.4.4 Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk A/S Key News
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Corporate Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Drugs for Hormonal Replacement Therapy Major Product Offerings
7.5.4 Eli Lilly and Company Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly and Company Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Drugs for Hormonal Replacement Therapy Major Product Offerings
7.6.4 Abbott Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.6.5 Abbott Key News
7.7 Mylan Laboratories
7.7.1 Mylan Laboratories Corporate Summary
7.7.2 Mylan Laboratories Business Overview
7.7.3 Mylan Laboratories Drugs for Hormonal Replacement Therapy Major Product Offerings
7.7.4 Mylan Laboratories Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.7.5 Mylan Laboratories Key News
7.8 Merck & Co.
7.8.1 Merck & Co. Corporate Summary
7.8.2 Merck & Co. Business Overview
7.8.3 Merck & Co. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.8.4 Merck & Co. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.8.5 Merck & Co. Key News
7.9 Hisamitsu Pharmaceutical Co. Inc.
7.9.1 Hisamitsu Pharmaceutical Co. Inc. Corporate Summary
7.9.2 Hisamitsu Pharmaceutical Co. Inc. Business Overview
7.9.3 Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.9.4 Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.9.5 Hisamitsu Pharmaceutical Co. Inc. Key News
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd. Key News
7.11 F.Hoffmann-La Roche
7.11.1 F.Hoffmann-La Roche Corporate Summary
7.11.2 F.Hoffmann-La Roche Business Overview
7.11.3 F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Major Product Offerings
7.11.4 F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.11.5 F.Hoffmann-La Roche Key News
7.12 Noven Pharmaceuticals Inc.
7.12.1 Noven Pharmaceuticals Inc. Corporate Summary
7.12.2 Noven Pharmaceuticals Inc. Business Overview
7.12.3 Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.12.4 Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.12.5 Noven Pharmaceuticals Inc. Key News
7.13 Orion Pharma AB
7.13.1 Orion Pharma AB Corporate Summary
7.13.2 Orion Pharma AB Business Overview
7.13.3 Orion Pharma AB Drugs for Hormonal Replacement Therapy Major Product Offerings
7.13.4 Orion Pharma AB Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.13.5 Orion Pharma AB Key News
7.14 Allergan Plc.
7.14.1 Allergan Plc. Corporate Summary
7.14.2 Allergan Plc. Business Overview
7.14.3 Allergan Plc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.14.4 Allergan Plc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.14.5 Allergan Plc. Key News
7.15 QuatRx Pharmaceuticals
7.15.1 QuatRx Pharmaceuticals Corporate Summary
7.15.2 QuatRx Pharmaceuticals Business Overview
7.15.3 QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Major Product Offerings
7.15.4 QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.15.5 QuatRx Pharmaceuticals Key News
7.16 Wyeth
7.16.1 Wyeth Corporate Summary
7.16.2 Wyeth Business Overview
7.16.3 Wyeth Drugs for Hormonal Replacement Therapy Major Product Offerings
7.16.4 Wyeth Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.16.5 Wyeth Key News
7.17 Amgen Inc.
7.17.1 Amgen Inc. Corporate Summary
7.17.2 Amgen Inc. Business Overview
7.17.3 Amgen Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.17.4 Amgen Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.17.5 Amgen Inc. Key News
7.18 Roche
7.18.1 Roche Corporate Summary
7.18.2 Roche Business Overview
7.18.3 Roche Drugs for Hormonal Replacement Therapy Major Product Offerings
7.18.4 Roche Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.18.5 Roche Key News
7.19 Genentech
7.19.1 Genentech Corporate Summary
7.19.2 Genentech Business Overview
7.19.3 Genentech Drugs for Hormonal Replacement Therapy Major Product Offerings
7.19.4 Genentech Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.19.5 Genentech Key News
7.20 TherapeuticsMD
7.20.1 TherapeuticsMD Corporate Summary
7.20.2 TherapeuticsMD Business Overview
7.20.3 TherapeuticsMD Drugs for Hormonal Replacement Therapy Major Product Offerings
7.20.4 TherapeuticsMD Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.20.5 TherapeuticsMD Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Hormonal Replacement Therapy Market Opportunities & Trends in Global Market
Table 2. Drugs for Hormonal Replacement Therapy Market Drivers in Global Market
Table 3. Drugs for Hormonal Replacement Therapy Market Restraints in Global Market
Table 4. Key Players of Drugs for Hormonal Replacement Therapy in Global Market
Table 5. Top Drugs for Hormonal Replacement Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Hormonal Replacement Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Hormonal Replacement Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Hormonal Replacement Therapy Product Type
Table 9. List of Global Tier 1 Drugs for Hormonal Replacement Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Hormonal Replacement Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2023-2030
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Drugs for Hormonal Replacement Therapy Product Offerings
Table 32. Novartis AG Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Bayer AG Corporate Summary
Table 34. Bayer AG Drugs for Hormonal Replacement Therapy Product Offerings
Table 35. Bayer AG Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 36. Pfizer Inc. Corporate Summary
Table 37. Pfizer Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 38. Pfizer Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 39. Novo Nordisk A/S Corporate Summary
Table 40. Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Product Offerings
Table 41. Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Drugs for Hormonal Replacement Therapy Product Offerings
Table 44. Eli Lilly and Company Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 45. Abbott Corporate Summary
Table 46. Abbott Drugs for Hormonal Replacement Therapy Product Offerings
Table 47. Abbott Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 48. Mylan Laboratories Corporate Summary
Table 49. Mylan Laboratories Drugs for Hormonal Replacement Therapy Product Offerings
Table 50. Mylan Laboratories Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Merck & Co. Corporate Summary
Table 52. Merck & Co. Drugs for Hormonal Replacement Therapy Product Offerings
Table 53. Merck & Co. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Hisamitsu Pharmaceutical Co. Inc. Corporate Summary
Table 55. Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 56. Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 57. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 58. Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Product Offerings
Table 59. Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 60. F.Hoffmann-La Roche Corporate Summary
Table 61. F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Product Offerings
Table 62. F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 63. Noven Pharmaceuticals Inc. Corporate Summary
Table 64. Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 65. Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 66. Orion Pharma AB Corporate Summary
Table 67. Orion Pharma AB Drugs for Hormonal Replacement Therapy Product Offerings
Table 68. Orion Pharma AB Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 69. Allergan Plc. Corporate Summary
Table 70. Allergan Plc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 71. Allergan Plc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 72. QuatRx Pharmaceuticals Corporate Summary
Table 73. QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Product Offerings
Table 74. QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 75. Wyeth Corporate Summary
Table 76. Wyeth Drugs for Hormonal Replacement Therapy Product Offerings
Table 77. Wyeth Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 78. Amgen Inc. Corporate Summary
Table 79. Amgen Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 80. Amgen Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 81. Roche Corporate Summary
Table 82. Roche Drugs for Hormonal Replacement Therapy Product Offerings
Table 83. Roche Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 84. Genentech Corporate Summary
Table 85. Genentech Drugs for Hormonal Replacement Therapy Product Offerings
Table 86. Genentech Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
Table 87. TherapeuticsMD Corporate Summary
Table 88. TherapeuticsMD Drugs for Hormonal Replacement Therapy Product Offerings
Table 89. TherapeuticsMD Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Drugs for Hormonal Replacement Therapy Segment by Type in 2022
Figure 2. Drugs for Hormonal Replacement Therapy Segment by Application in 2022
Figure 3. Global Drugs for Hormonal Replacement Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Hormonal Replacement Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Hormonal Replacement Therapy Revenue in 2022
Figure 8. By Type - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 10. By Region - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 11. By Country - North America Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 12. US Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 16. Germany Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. France Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 24. China Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 28. India Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 30. Brazil Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2030
Figure 33. Turkey Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2030
Figure 37. Novartis AG Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Bayer AG Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Pfizer Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Eli Lilly and Company Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mylan Laboratories Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Orion Pharma AB Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Allergan Plc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Wyeth Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Amgen Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Roche Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Genentech Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. TherapeuticsMD Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
